ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 116 filers reported holding ACCELERON PHARMA INC in Q2 2015. The put-call ratio across all filers is 1.90 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $53,563,000 | +6.5% | 1,480,060 | 0.0% | 85.86% | +3.0% |
Q2 2016 | $50,292,000 | +28.8% | 1,480,060 | 0.0% | 83.36% | +13.4% |
Q1 2016 | $39,059,000 | -45.9% | 1,480,060 | 0.0% | 73.52% | -7.8% |
Q4 2015 | $72,168,000 | +95.8% | 1,480,060 | 0.0% | 79.74% | +23.1% |
Q3 2015 | $36,853,000 | -38.3% | 1,480,060 | -21.6% | 64.78% | +4.3% |
Q2 2015 | $59,715,000 | -34.5% | 1,887,319 | -21.2% | 62.12% | -18.3% |
Q1 2015 | $91,207,000 | -9.3% | 2,396,389 | -7.1% | 76.05% | -4.0% |
Q4 2014 | $100,528,000 | +18.6% | 2,580,291 | -8.0% | 79.21% | +0.8% |
Q3 2014 | $84,782,000 | -11.0% | 2,803,645 | 0.0% | 78.57% | +1.0% |
Q2 2014 | $95,240,000 | -16.8% | 2,803,645 | -15.5% | 77.81% | +3.0% |
Q1 2014 | $114,441,000 | -7.8% | 3,317,136 | +5.9% | 75.52% | -8.4% |
Q4 2013 | $124,076,000 | – | 3,133,234 | – | 82.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |